MPO myeloperoxidase
Selected indexed studies
- Myeloperoxidase transforms chromatin into neutrophil extracellular traps. (Nature, 2025) [PMID:40963017]
- Single-cell spatial immune landscapes of primary and metastatic brain tumours. (Nature, 2023) [PMID:36725935]
- Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies. (Autoimmun Rev, 2008) [PMID:18558355]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Myeloperoxidase transforms chromatin into neutrophil extracellular traps. (2025) pubmed
- Single-cell spatial immune landscapes of primary and metastatic brain tumours. (2023) pubmed
- Natural and disease associated anti-myeloperoxidase (MPO) autoantibodies. (2008) pubmed
- MPO (Myeloperoxidase) Reduces Endothelial Glycocalyx Thickness Dependent on Its Cationic Charge. (2018) pubmed
- Inhibition of Myeloperoxidase. (2021) pubmed
- Biosynthesis of human myeloperoxidase. (2018) pubmed
- 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. (2022) pubmed
- The other myeloperoxidase: Emerging functions. (2018) pubmed
- SNP rs2243828 in MPO associated with myeloperoxidase level and atrial fibrillation risk in Chinese Han population. (2020) pubmed
- A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT). (2021) pubmed